Intravitreal faricimab in patients with nAMD: French data from the Fight Retinal Blindness! Registry.

چکیده

To assess real-world outcomes of intravitreal faricimab in French patients with neovascular age-related macular degeneration (nAMD) previously treated with vascular endothelial growth factor (VEGF) inhibitors using data from the Fight Retinal Blindness! (FRB!) Registry. Retrospective analysis of…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• کم بینایی و توانبخشی
• شبکیه